Metabolomics predicts the pharmacological profile of new psychoactive substances > GIAS | 2019 | Publicaciones Autor: Olesti E. y otros Revista: J Psychopharmacol Fuente: NCBI-PubMed Volver a Publicaciones ← Cannabinoids: from pot to lab Cardiovascular disease burden among human immunodeficiency virus-infected individuals →